Literature DB >> 25904501

Comment on "prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases".

David G Watt1, Paul G Horgan, Donald C McMillan.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25904501     DOI： 10.1007/s12032-015-0617-8

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


× No keyword cloud information.
  7 in total

1.  Neutrophil count is the most important prognostic component of the differential white cell count in patients undergoing elective surgery for colorectal cancer.

Authors:  David G Watt; John C Martin; James H Park; Paul G Horgan; Donald C McMillan
Journal:  Am J Surg       Date:  2015-03-12       Impact factor: 2.565

2.  Optimization of the systemic inflammation-based Glasgow prognostic score: a Glasgow Inflammation Outcome Study.

Authors:  Michael J Proctor; Paul G Horgan; Dinesh Talwar; Colin D Fletcher; David S Morrison; Donald C McMillan
Journal:  Cancer       Date:  2013-04-10       Impact factor: 6.860

3.  Prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases.

Authors:  Christopher P Neal; Vaux Cairns; Michael J Jones; Muhammad M Masood; Gael R Nana; Christopher D Mann; Giuseppe Garcea; Ashley R Dennison
Journal:  Med Oncol       Date:  2015-03-26       Impact factor: 3.064

Review 4.  The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer.

Authors:  Graeme J K Guthrie; Kellie A Charles; Campbell S D Roxburgh; Paul G Horgan; Donald C McMillan; Stephen J Clarke
Journal:  Crit Rev Oncol Hematol       Date:  2013-04-17       Impact factor: 6.312

Review 5.  Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis.

Authors:  Arnoud J Templeton; Mairéad G McNamara; Boštjan Šeruga; Francisco E Vera-Badillo; Priya Aneja; Alberto Ocaña; Raya Leibowitz-Amit; Guru Sonpavde; Jennifer J Knox; Ben Tran; Ian F Tannock; Eitan Amir
Journal:  J Natl Cancer Inst       Date:  2014-05-29       Impact factor: 13.506

6.  The neutrophil-lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials.

Authors:  R Kumar; E Geuna; V Michalarea; M Guardascione; U Naumann; D Lorente; S B Kaye; J S de Bono
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

7.  Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer.

Authors:  E F Leitch; M Chakrabarti; J E M Crozier; R F McKee; J H Anderson; P G Horgan; D C McMillan
Journal:  Br J Cancer       Date:  2007-10-09       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.